NO923673L - Nye nitrogencykliske ligander, fremgangsmaate for deres fremstilling, polymetallkomplekser og et diagnostisk og terapeutisk preparat - Google Patents
Nye nitrogencykliske ligander, fremgangsmaate for deres fremstilling, polymetallkomplekser og et diagnostisk og terapeutisk preparatInfo
- Publication number
- NO923673L NO923673L NO92923673A NO923673A NO923673L NO 923673 L NO923673 L NO 923673L NO 92923673 A NO92923673 A NO 92923673A NO 923673 A NO923673 A NO 923673A NO 923673 L NO923673 L NO 923673L
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- ligands
- diagnostic
- image
- nitrogencyclic
- Prior art date
Links
- 239000003446 ligand Substances 0.000 title abstract 3
- 238000000034 method Methods 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- 150000003839 salts Chemical class 0.000 abstract 2
- 229910052769 Ytterbium Inorganic materials 0.000 abstract 1
- 229910052788 barium Inorganic materials 0.000 abstract 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 abstract 1
- 229910052797 bismuth Inorganic materials 0.000 abstract 1
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000000032 diagnostic agent Substances 0.000 abstract 1
- 229940039227 diagnostic agent Drugs 0.000 abstract 1
- 238000006073 displacement reaction Methods 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 229910021644 lanthanide ion Inorganic materials 0.000 abstract 1
- 238000002595 magnetic resonance imaging Methods 0.000 abstract 1
- 229910021645 metal ion Inorganic materials 0.000 abstract 1
- 238000009206 nuclear medicine Methods 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
- 229910001428 transition metal ion Inorganic materials 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
- A61K51/0482—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group chelates from cyclic ligands, e.g. DOTA
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/24—Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Optics & Photonics (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9100811A FR2672051B1 (fr) | 1991-01-24 | 1991-01-24 | Nouveaux ligands macrocycliques azotes, procede de preparation, complexes polymetalliques, composition de diagnostic et therapeutique. |
| PCT/FR1992/000057 WO1992012978A1 (fr) | 1991-01-24 | 1992-01-22 | Nouveaux ligands macrocycliques azotes, procede de preparation, complexes polymetalliques, composition de diagnostic et therapeutique |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO923673D0 NO923673D0 (no) | 1992-09-22 |
| NO923673L true NO923673L (no) | 1992-11-24 |
Family
ID=9409017
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO92923673A NO923673L (no) | 1991-01-24 | 1992-09-22 | Nye nitrogencykliske ligander, fremgangsmaate for deres fremstilling, polymetallkomplekser og et diagnostisk og terapeutisk preparat |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US5374416A (cs) |
| EP (1) | EP0499501B1 (cs) |
| JP (1) | JPH0735381B2 (cs) |
| KR (1) | KR960014355B1 (cs) |
| AT (1) | ATE169916T1 (cs) |
| AU (1) | AU650325B2 (cs) |
| CA (1) | CA2078983A1 (cs) |
| CZ (1) | CZ281225B6 (cs) |
| DE (1) | DE69226669T2 (cs) |
| FR (1) | FR2672051B1 (cs) |
| HU (1) | HUT70023A (cs) |
| IE (1) | IE920204A1 (cs) |
| IL (1) | IL100717A (cs) |
| MX (1) | MX9200319A (cs) |
| NO (1) | NO923673L (cs) |
| NZ (1) | NZ241356A (cs) |
| WO (1) | WO1992012978A1 (cs) |
| ZA (1) | ZA92470B (cs) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69024826T2 (de) * | 1989-02-10 | 1996-06-27 | Celltech Therapeutics Ltd | Aza-Macrozyklen und Verfahren zu deren Herstellung |
| US5645818A (en) * | 1989-03-24 | 1997-07-08 | Guerbet S.A. | Diagnostic compositions comprising a complex formed by a nitrogenous macrocyclic ligand with metal ions |
| GB9126677D0 (en) | 1991-12-16 | 1992-02-12 | Johnson Matthey Plc | Improvements in chemical compounds |
| US5462725A (en) * | 1993-05-06 | 1995-10-31 | The Dow Chemical Company | 2-pyridylmethylenepolyazamacrocyclophosphonic acids, complexes and derivatives thereof, for use as contrast agents |
| DE4318369C1 (de) * | 1993-05-28 | 1995-02-09 | Schering Ag | Verwendung von makrocyclischen Metallkomplexen als Temperatursonden |
| US6693190B1 (en) | 1994-05-11 | 2004-02-17 | Bracco International B.V. | Enhanced relaxivity monomeric and multimeric compounds |
| EP0977828B1 (en) * | 1997-03-07 | 2005-05-11 | The Procter & Gamble Company | Bleach compositions |
| US20080125344A1 (en) * | 2006-11-28 | 2008-05-29 | Daryle Hadley Busch | Bleach compositions |
| US20030017941A1 (en) * | 1997-03-07 | 2003-01-23 | The Procter & Gamble Company | Catalysts and methods for catalytic oxidation |
| ZA981883B (en) * | 1997-03-07 | 1998-09-01 | Univ Kansas | Catalysts and methods for catalytic oxidation |
| US20050187126A1 (en) * | 2002-08-27 | 2005-08-25 | Busch Daryle H. | Catalysts and methods for catalytic oxidation |
| US6565828B2 (en) | 2000-04-07 | 2003-05-20 | Bristol-Myers Squibb Company | Macrocyclic chelants for metallopharmaceuticals |
| RU2311413C2 (ru) * | 2000-09-29 | 2007-11-27 | Анормед, Инк. | Циклические полиамины, содержащие в кольце n атомов азота, защищенных по принципу "все, кроме одного (n-1)", и способы их получения |
| DE10117242C1 (de) * | 2001-04-06 | 2002-05-16 | Schering Ag | Unsymmetrische dimere Metallkomplexe, Liganden für diese Metallkomplexe, Verfahren zu deren Herstellung, Arzneimittel bzw. Diagnosemittel, die die Metallkomplexe enthalten, insbesondere Kontrastmittel |
| MXPA04000982A (es) * | 2001-07-31 | 2004-04-20 | Anormed Inc | Metodos para movilizar celulas progenitoras/madre. |
| US20040048763A1 (en) * | 2002-08-27 | 2004-03-11 | The Procter & Gamble Co. | Bleach compositions |
| EP1637524A1 (en) * | 2004-09-20 | 2006-03-22 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | 10-substituted 1-, 4, 7,-tris (carboxymethyl)-1,4,7,10-tetraazacyclo-dodecane derivative for use as contrast agents |
| TWI429404B (zh) * | 2008-03-03 | 2014-03-11 | Senomyx Inc | 異山梨醇衍生物及彼等作為風味改良劑、促味劑及促味增強劑之用途 |
| JP5735791B2 (ja) * | 2010-12-07 | 2015-06-17 | 住友化学株式会社 | 金属錯体を含む素子 |
| FR2968999B1 (fr) | 2010-12-20 | 2013-01-04 | Guerbet Sa | Nanoemulsion de chelate pour irm |
| US10918742B2 (en) | 2016-03-25 | 2021-02-16 | Nanoprobes, Inc. | Iodine-based particles |
| WO2017178301A1 (en) | 2016-04-13 | 2017-10-19 | Bracco Imaging Spa | Contrast agents |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS53144592A (en) * | 1977-05-19 | 1978-12-15 | Tabuse Iwao | 122alkyll1*4*7*100tetrazacyclotridecane |
| EP0466200B1 (en) * | 1987-07-16 | 1996-04-24 | Nycomed Imaging As | Aminocarboxylic acids and derivatives thereof |
| DE3728525A1 (de) * | 1987-08-24 | 1989-03-16 | Schering Ag | Mehrkernige substituierte komplexbildner, komplexe und komplexsalze, verfahren zu deren herstellung und diese enthaltende pharmazeutische mittel |
| WO1990007261A2 (en) * | 1988-12-22 | 1990-07-12 | The Dow Chemical Company | Process for preparing mono-n-alkylated polyazamacrocycles |
-
1991
- 1991-01-24 FR FR9100811A patent/FR2672051B1/fr not_active Expired - Fee Related
-
1992
- 1992-01-21 IL IL10071792A patent/IL100717A/en not_active IP Right Cessation
- 1992-01-22 CA CA002078983A patent/CA2078983A1/fr not_active Abandoned
- 1992-01-22 EP EP92400174A patent/EP0499501B1/fr not_active Expired - Lifetime
- 1992-01-22 KR KR1019920702286A patent/KR960014355B1/ko active IP Right Grant
- 1992-01-22 US US07/924,016 patent/US5374416A/en not_active Expired - Fee Related
- 1992-01-22 CZ CS922909A patent/CZ281225B6/cs unknown
- 1992-01-22 WO PCT/FR1992/000057 patent/WO1992012978A1/fr active IP Right Grant
- 1992-01-22 JP JP4505010A patent/JPH0735381B2/ja not_active Expired - Lifetime
- 1992-01-22 AU AU12562/92A patent/AU650325B2/en not_active Ceased
- 1992-01-22 NZ NZ241356A patent/NZ241356A/en unknown
- 1992-01-22 HU HU9203029A patent/HUT70023A/hu unknown
- 1992-01-22 DE DE69226669T patent/DE69226669T2/de not_active Expired - Fee Related
- 1992-01-22 AT AT92400174T patent/ATE169916T1/de not_active IP Right Cessation
- 1992-01-23 ZA ZA92470A patent/ZA92470B/xx unknown
- 1992-01-23 IE IE020492A patent/IE920204A1/en unknown
- 1992-01-24 MX MX9200319A patent/MX9200319A/es unknown
- 1992-09-22 NO NO92923673A patent/NO923673L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NZ241356A (en) | 1995-02-24 |
| HUT70023A (en) | 1995-09-28 |
| ATE169916T1 (de) | 1998-09-15 |
| ZA92470B (en) | 1993-07-23 |
| EP0499501A3 (fr) | 1992-08-26 |
| FR2672051A1 (fr) | 1992-07-31 |
| CZ281225B6 (cs) | 1996-07-17 |
| IL100717A0 (en) | 1992-09-06 |
| MX9200319A (es) | 1992-07-01 |
| NO923673D0 (no) | 1992-09-22 |
| EP0499501B1 (fr) | 1998-08-19 |
| CZ290992A3 (en) | 1993-02-17 |
| HU9203029D0 (en) | 1992-12-28 |
| IE920204A1 (en) | 1992-07-29 |
| EP0499501A2 (fr) | 1992-08-19 |
| AU650325B2 (en) | 1994-06-16 |
| AU1256292A (en) | 1992-08-27 |
| IL100717A (en) | 1996-06-18 |
| US5374416A (en) | 1994-12-20 |
| CA2078983A1 (fr) | 1992-07-25 |
| DE69226669D1 (de) | 1998-09-24 |
| DE69226669T2 (de) | 1999-04-15 |
| FR2672051B1 (fr) | 1993-05-21 |
| WO1992012978A1 (fr) | 1992-08-06 |
| JPH05504361A (ja) | 1993-07-08 |
| KR960014355B1 (ko) | 1996-10-15 |
| JPH0735381B2 (ja) | 1995-04-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO923673L (no) | Nye nitrogencykliske ligander, fremgangsmaate for deres fremstilling, polymetallkomplekser og et diagnostisk og terapeutisk preparat | |
| DE69019584D1 (de) | Makrocyclische Stickstoffliganden Verfahren zu ihrer Herstellung, ihre Metallkomplexe, sie enthaltende Diagnostische und therapeutische Mittel. | |
| Holman et al. | Comparison of magnetic resonance imaging studies with enzymatic indexes of myocardial necrosis for quantification of myocardial infarct size | |
| DE3855239T2 (de) | Aminocarbonsäure und Derivate | |
| ES2626582T5 (es) | Formulación de producto de contraste y su procedimiento de preparación asociado | |
| IL109852A0 (en) | Iodinated paramagnetic chelates | |
| JPH04500964A (ja) | キレート組成物 | |
| US4027005A (en) | Diagnostic agents | |
| JPH04169540A (ja) | 腎機能測定用の既放射能標識テクネチウムキレート注射剤の製造方法 | |
| AU8945891A (en) | Technetium-99m complexes for use as radiopharmaceuticals | |
| JPH04154729A (ja) | 磁気共鳴造影剤 | |
| EP1355913A4 (en) | COMPOUNDS BASED ON PARAMAGNETIC METAL COMPLEXES AND PHTALOCYANINE AND CONTRAST AGENT COMPRISING THESE COMPOUNDS | |
| CN109770937A (zh) | 一种心内科用可自动调整位置的心脏造影手术装置 | |
| EP1719754B1 (en) | Metal complexes of DTPA derivatives , and radiation source including the metal complexes | |
| CN210056058U (zh) | 一种放射线检查保护装置 | |
| GR3023954T3 (en) | Derivated dtpa complexes, pharmaceuticals containing these compounds, their use as nmr- and radiographic contrasting agents and process for producing the same. | |
| DE4340809C2 (de) | 1.4,7,10-Tetraazacyclododecan-Derivate, diese enthaltende pharmazeutische Mittel und Verfahren zu deren Herstellung | |
| Fleay | 99mTc‐Labelled EDTA for Renal Scanning | |
| Michell et al. | Angiography of the coronary circulation in living dogs using timed diastolic injections | |
| Lufkin | Severe anaphylactoid reaction to Gd-DTPA | |
| SUD et al. | Radioiodine uptake following thyroidectomy for thyroid cancer: Recurrence or ectopic tissue? | |
| Tully et al. | Renal scan prior to renal biopsy—a method of renal localization | |
| CA1070242A (en) | Radioactive diagnostic composition | |
| Park | Competition and the Role of Technology: An Assessment of the Medical Equipment Industry | |
| Kopp et al. | Radiation Protection in the intra-and post-operative diagnosis of the sentinel lymph node (SLN) |